文献速递血液净化与透析

起始血液透析患者动静脉通路类型与住院及死亡风险

Arteriovenous access creation and hazards of hospitalization and death in patients starting hemodialysis.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

结果显示移植血管与全因住院(wHR 1.08)及血管通路相关住院(wHR 1.43)风险升高相关,死亡及其他原因住院未见明确关联。

要点

  • 以导管起始血透者中,移植血管较动静脉瘘全因住院风险轻度升高(wHR 1.08)。
  • 移植血管与血管通路相关住院风险升高最明显(wHR 1.43)。
  • 死亡及心血管、感染相关住院风险未见明确升高。

核心结论

  • 在以导管起始血液透析的患者中,首次建立动静脉移植血管较动静脉瘘与血管通路相关住院风险升高相关,死亡或其他原因住院可能并非如此。

研究设计与样本

  • 通过法国国家健康行政数据库识别首次建立的动静脉瘘或移植血管,采用联合脆弱模型处理反复住院和死亡竞争风险,并用逆概率加权控制混杂。

主要发现

  • 移植血管与全因住院的加权风险比(wHR)为1.08(95%CI 1.02至1.15)。
  • 移植血管与血管通路相关住院的wHR为1.43(95%CI 1.32至1.55)。
  • 移植血管与心血管相关住院的wHR为1.14(95%CI 1.03至1.26),与感染相关住院的wHR为1.11(95%CI 0.97至1.28)。
  • 在合并症(如糖尿病)患者中,移植血管与全因、心血管及感染相关住院的最高风险减弱:全因wHR 1.01(95%CI 0.93至1.10),心血管wHR 1.10(95%CI 0.96至1.26),感染wHR 0.94(95%CI 0.78至1.12)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent evidence suggests an overestimation of the benefits associated with arteriovenous (AV) fistula versus graft in certain populations. We assessed hazards of all-cause and cause-specific hospitalization and death associated with AV access type in patients who started hemodialysis with a catheter in France, overall and by subgroups of age, sex and comorbidities. METHODS: We performed a target trial emulation including patients who initiated hemodialysis with a catheter from 2010 through 2018 and were followed by the REIN Registry. We identified first-created fistula or graft through the French national health-administrative database. We used joint frailty models to deal with recurrent hospitalizations and potential informative censoring by death, and inverse probability weighting to account for confounding. RESULTS: From the 18 800 patients included (mean age 68 ± 15 years, 35% women), 5% underwent AV graft creation first. The weighted hazard ratio (wHR) of all-cause hospitalization associated with graft was 1.08 [95% confidence interval (CI) 1.02 to 1.15], that of vascular access-related hospitalization was 1.43 (95% CI 1.32 to 1.55), and those of cardiovascular- and infection-related hospitalizations were 1.14 (95% CI 1.03 to 1.26) and 1.11 (95% CI 0.97 to 1.28), respectively. Results were consistent for most subgroups, except that the highest hazard of all-cause, cardiovascular- and infection-related hospitalizations with graft was blunted in patients with comorbidities (i.e. diabetes, wHR 1.01, 95% CI 0.93 to 1.10; 1.10, 95% CI 0.96 to 1.26; and 0.94, 95% CI 0.78 to 1.12, respectively). CONCLUSIONS: In patients starting hemodialysis with a catheter, AV graft creation is associated with increased hazard of vascular access-related hospitalizations compared with fistula. This may not be the case for death or other causes of hospitalization.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Alencar de Pinho N, Prezelin-Reydit M, Harambat J, et al. Arteriovenous access creation and hazards of hospitalization and death in patients starting hemodialysis. Nephrol Dial Transplant. 2024. PMID: 38012126. doi:10.1093/ndt/gfad251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。